Abstract Background Previously, 50% of patients with breast ductal carcinoma in situ (DCIS) had more than one nuclear grade, and neither worst nor predominant nuclear grade was significantly associated with development of invasive carcinoma. Here, we used image analysis in addition to histologic evaluation to determine if quantification of nuclear features could provide additional prognostic information and hence impact prognostic assessments. Methods Nuclear image features were extracted from about 200 nuclei of each of 80 patients with DCIS who underwent lumpectomy alone, and received no adjuvant systemic therapy. Nuclear images were obtained from 20 representative nuclei per duct, from each of a group of 5 ducts, in two separate fields, ...
Ductal carcinoma in situ (DCIS) is currently considered an early and localized form of ductal breast...
The chromatin pattern in nuclei from breast ductal proliferative lesions was quantitatively evaluate...
Ductal carcinoma in situ (DCIS) is a heterogeneous malignant condition of the breast with an excelle...
Abstract Background Previously, 50% of patients with ...
Background Nuclear grade has been associated with breast DCIS recurrence and progression to invasive...
BACKGROUND: Oncotype DX (ODx) is a 12-gene assay assessing the recurrence risk (high, intermediate, ...
Clinical management of ductal carcinoma in situ (DCIS) remains a challenge because significant propo...
Except of the diagnostic categories based on the morphology of cells and tissue there are currently...
Abnormalities in cell nuclear morphology are a hallmark of cancer. Histological assessment of cell n...
AIMS: The objective of this study is to derive highly specific nuclear signatures (NS's) for the cha...
AIMS: Robust prognostic markers for ductal carcinoma in situ (DCIS) of the breast require high repro...
AIMS: Robust prognostic markers for ductal carcinoma in situ (DCIS) of the breast require high repro...
Background Low nuclear grade ductal carcinoma in situ (DCIS) identified at biopsy can be upgraded to...
Nuclei in ducts visually described as having the same nuclear grade had significantly different subv...
Purpose For optimal management of ductal carcinoma in situ (DCIS), reproducible histopathological as...
Ductal carcinoma in situ (DCIS) is currently considered an early and localized form of ductal breast...
The chromatin pattern in nuclei from breast ductal proliferative lesions was quantitatively evaluate...
Ductal carcinoma in situ (DCIS) is a heterogeneous malignant condition of the breast with an excelle...
Abstract Background Previously, 50% of patients with ...
Background Nuclear grade has been associated with breast DCIS recurrence and progression to invasive...
BACKGROUND: Oncotype DX (ODx) is a 12-gene assay assessing the recurrence risk (high, intermediate, ...
Clinical management of ductal carcinoma in situ (DCIS) remains a challenge because significant propo...
Except of the diagnostic categories based on the morphology of cells and tissue there are currently...
Abnormalities in cell nuclear morphology are a hallmark of cancer. Histological assessment of cell n...
AIMS: The objective of this study is to derive highly specific nuclear signatures (NS's) for the cha...
AIMS: Robust prognostic markers for ductal carcinoma in situ (DCIS) of the breast require high repro...
AIMS: Robust prognostic markers for ductal carcinoma in situ (DCIS) of the breast require high repro...
Background Low nuclear grade ductal carcinoma in situ (DCIS) identified at biopsy can be upgraded to...
Nuclei in ducts visually described as having the same nuclear grade had significantly different subv...
Purpose For optimal management of ductal carcinoma in situ (DCIS), reproducible histopathological as...
Ductal carcinoma in situ (DCIS) is currently considered an early and localized form of ductal breast...
The chromatin pattern in nuclei from breast ductal proliferative lesions was quantitatively evaluate...
Ductal carcinoma in situ (DCIS) is a heterogeneous malignant condition of the breast with an excelle...